Global Blood Clotting Factor Market, By Product (Clinical Laboratory Analysers and Point-Of-Care Testing Analysers), Test (Prothrombin Time Testing, Fibrinogen Testing, Activated Partial Thromboplastin Time Testing , Activated Clotting Time Testing , D-Dimer Testing, Platelet Function Tests , Anti-Factor Xa Tests, Heparin and Protamine Dose Response Tests for ACT and Others), Technology (Mechanical Technology, Optical Technology, Electrochemical Technology and Others), Application (Bleeding Disorders, Acquired Bleeding Disorders, Von Willebrand Disease and Haemophilia), End User (Academic Institutions, Hospitals, Diagnostic Laboratories and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Data Bridge Market Research analyses that the blood clotting factor will exhibit a CAGR of around 8.70% for the forecast period of 2021-2028. Rising prevalence of strokes, surge in the research and development activities for the development of novel drugs and therapies and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of blood clotting factor market.
Blood clotting factors are the enzymes or proteins that control bleeding. Blood clotting helps to prevent the entry of bacteria into the body and also can prevent death as a result of excessive bleeding.
Growing prevalence of road accidents is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure and upsurge in the incidences of cardiovascular diseases and blood disorders are other factors also fostering the growth of the market. Increasing personal disposable income and growing demand for laboratory automation are some other indirect determinants that will create lucrative market growth opportunities.
However, non-favourable reimbursement scenario in the developing and under developed economies will pose a major challenge to the market growth. Also, high costs associated with fully automated coagulation analysers coupled with shortage of plasma supply will further derail the market growth rate. Lack of awareness in the backward areas will also put a halt on the market growth rate.
This blood clotting factor market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on blood clotting factor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Blood Clotting Factor Market Scope and Market Size
The blood clotting factor market is segmented on the basis of product, test, technology, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the blood clotting factor market is segmented into clinical laboratory analysers and point-of-care testing analysers. Clinical laboratory analysers segment is sub-segmented into consumables and systems. Systems segment is further segmented into automated systems, semi-automated systems and manual systems.
- On the basis of test, the blood clotting factor market is segmented into prothrombin time testing, fibrinogen testing, activated partial thromboplastin time testing , activated clotting time testing , D-dimer testing, platelet function tests , anti-factor Xa tests, heparin and protamine dose response tests for ACT and others.
- On the basis of technology, the blood clotting factor market is segmented into mechanical technology, optical technology, electrochemical technology and others.
- On the basis of application, the blood clotting factor market is segmented into bleeding disorders, acquired bleeding disorders, von willebrand disease and haemophilia.
- On the basis of end user, the blood clotting factor market is segmented into academic institutions, hospitals, diagnostic laboratories and others.
Blood Clotting Factor Market Country Level Analysis
The blood clotting factor market is analysed and market size insights and trends are provided by country, product, test, technology, application and end user as referenced above.
The countries covered in the blood clotting factor market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the blood clotting factor market owing to the rising expenditure for the development of research and development proficiencies, surge in the number of patients with blood disorders, high yield of plasma products and favourable reimbursement scenario in this region. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure, growing initiatives by the government to spread awareness, rising product launch by the market players and increasing personal disposable income.
The country section of the blood clotting factor market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The blood clotting factor market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Blood Clotting Factor Market Share Analysis
The blood clotting factor market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to blood clotting factor market.
The major players covered in the blood clotting factor market report are Eurofins Scientific, Quest Diagnostics Incorporated, Novogene Corporation, Promega Corporation, Luminex Corporation, Takara Bio Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., BioIVT., Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc, GENERAL ELECTRIC COMPANY, PerkinElmer Inc., QIAGEN,, Danaher, Octapharma AG, Interpace Biosciences, Inc. and Novo Nordisk A/S among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Blood Clotting Factor Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.